Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma.
Grisendi G, Dall'Ora M, Casari G, Spattini G, Farshchian M, Melandri A, Masicale V, Lepore F, Banchelli F, Costantini RC, D'Esposito A, Chiavelli C, Spano C, Spallanzani A, Petrachi T, Veronesi E, Ferracin M, Roncarati R, Vinet J, Magistri P, Catellani B, Candini O, Marra C, Eccher A, Bonetti LR, Horwtiz EM, Di Benedetto F, Dominici M.
Grisendi G, et al. Among authors: vinet j.
Cell Rep Med. 2024 Aug 20;5(8):101685. doi: 10.1016/j.xcrm.2024.101685.
Cell Rep Med. 2024.
PMID: 39168103
Free PMC article.